More on MYGN

- Summary
- Chart
- Profile
- Historical


- Earnings (+116.7% Growth)
- Ratings (2.9 Score)
- Holders


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/28/24)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

MYGN Income Statement

Click line-items for a historical chart and %
Consolidated Statements Of Income
Molecular diagnostic testing 165.1M
Companion diagnostic services 12.4M
Total revenue 177.5M
Costs and expenses:
Cost of molecular diagnostic testing 34.3M
Cost of companion diagnostic services
Research and development expense 19.4M
Selling, general, and administrative expense 111.9M
Total costs and expenses 171.3M
Operating income 6.2M
Other income (expense):
Interest income 300K
Total other income
Income from continuing operations before income taxes 4M
Income tax provision (benefit) 5.2M
Income from continuing operations
Discontinued operations (Note 15)
Loss from discontinued operations
Net income -1.2M
Earnings (loss) per basic share
Continuing operations
Discontinued operations
Earnings per basic share -0.02
Earnings (loss) per diluted share
Continuing operations
Discontinued operations
Earnings per diluted share -0.02
Weighted average shares outstanding
Basic 68.8M
Diluted 68.8M